Product and Service [Axis]
Product [Member]
License [Member]
Equity Components [Axis]
Common Stock [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Coflex/CoFix Agreement [Member]
Business Combination [Axis]
Companion Spine Llc [Member]
Paradigm Spine Gmbh [Member]
Bill and Hold Transactions [Member]
Orthobiologics [Member]
Spinal Implant [Member]
License Revenue [Member]
Long-Lived Asset, Class [Axis]
Equipment [Member]
Computer Equipment [Member]
Computer Software [Member]
Leasehold Improvements [Member]
Surgical Instruments [Member]
Assets not yet in Service [Member]
Intangible Asset, Finite-Lived, Class [Axis]
Patents [Member]
Debt Instrument [Axis]
Remainder of 2026 [Member]
2027 [Member]
2028 [Member]
2029 [Member]
Term Credit Agreement [Member]
Revolving Credit Agreement [Member]
Credit Facility [Axis]
Revolving Credit Facility [Member]
Plan Name [Axis]
2023 Equity Incentive Plan [Member]
2018 Equity Incentive Plan [Member]
Title and Position [Axis]
Employees and Directors [Member]
Award Type [Axis]
Share-Based Payment Arrangement, Option [Member]
Deferred Stock Units and Restricted Stock Units [Member]
Performance Shares [Member]
Statistical Measurement [Axis]
Minimum [Member]
Maximum [Member]
2023 and 2018 Equity Incentive Plan [Member]
Warrant [Member]
Concentration Risk Type [Axis]
Customer Concentration Risk [Member]
Concentration Risk Benchmark [Axis]
Revenue from Contract with Customer Benchmark [Member]
Geographical [Axis]
UNITED STATES
Non-US [Member]
Distribution Agreement [Member]
Subsequent Event Type [Axis]
Subsequent Event [Member]
Cover [Abstract]
Document Type
Amendment Flag
Amendment Description
Document Registration Statement
Document Annual Report
Document Quarterly Report
Document Transition Report
Document Shell Company Report
Document Shell Company Event Date
Document Period Start Date
Document Period End Date
Document Fiscal Period Focus
Document Fiscal Year Focus
Current Fiscal Year End Date
Entity File Number
Entity Registrant Name
Entity Central Index Key
Entity Primary SIC Number
Entity Tax Identification Number
Entity Incorporation, State or Country Code
Entity Address, Address Line One
Entity Address, Address Line Two
Entity Address, Address Line Three
Entity Address, City or Town
Entity Address, State or Province
Entity Address, Country
Entity Address, Postal Zip Code
Country Region
City Area Code
Local Phone Number
Extension
Written Communications
Soliciting Material
Pre-commencement Tender Offer
Pre-commencement Issuer Tender Offer
Title of 12(b) Security
No Trading Symbol Flag
Trading Symbol
Security Exchange Name
Title of 12(g) Security
Security Reporting Obligation
Annual Information Form
Audited Annual Financial Statements
Entity Well-known Seasoned Issuer
Entity Voluntary Filers
Entity Current Reporting Status
Entity Interactive Data Current
Entity Filer Category
Entity Small Business
Entity Emerging Growth Company
Elected Not To Use the Extended Transition Period
Document Accounting Standard
Other Reporting Standard Item Number
Entity Shell Company
Entity Public Float
Entity Bankruptcy Proceedings, Reporting Current
Entity Common Stock, Shares Outstanding
Documents Incorporated by Reference [Text Block]
Statement of Financial Position [Abstract]
ASSETS
Current Assets:
Cash and cash equivalents
Restricted cash
Trade accounts receivable, net of allowance for credit losses of $2,115 and $2,165, respectively
Inventories
Note receivable
Prepaid and other current assets
Total current assets
Property and equipment, net
Right-of-use asset, net
Goodwill
Intangible assets, net
Other assets
Total Assets
LIABILITIES & STOCKHOLDERS’ EQUITY
Current Liabilities:
Accounts payable
Accrued liabilities
Current portion of long-term debt
Current portion of lease liability
Current portion of finance lease obligations
Line of credit
Total current liabilities
Long-term Liabilities:
Lease liability, less current portion
Finance lease obligation, less current portion
Long-term debt, plus premium and less issuance costs
Other liabilities
Total Liabilities
Commitments and Contingencies (Note 12)
Stockholders’ Equity:
Preferred stock, $0.000001 par value; 10,000,000 shares authorized; no shares issued and outstanding
Common stock, $0.000001 par value; 300,000,000 shares authorized; 140,068,260 shares issued and outstanding as of March 31, 2026 and 140,039,557 shares issued and outstanding as of December 31, 2025
Additional paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
Total Stockholders’ Equity
Total Liabilities & Stockholders’ Equity
Allowance for credit losses, net
Preferred stock, par value
Preferred stock, shares authorized
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value
Common stock, shares authorized
Common stock, shares issued
Common stock, shares outstanding
Statement [Table]
Statement [Line Items]
Revenue
Total Revenue
Cost of Sales
Gross Profit
Operating Expenses
General and administrative
Sales and marketing
Research and development
Total Operating Expenses
(Loss) Income from Operations
Other Expense
Interest expense
Interest income
Unrealized foreign currency translation (loss) gain
Other income (expense)
Total Other Expense
Net (Loss) Income from Operations Before Provision for Income Taxes
(Provision) Benefit for Income Taxes Current and Deferred
Net (Loss) Income
Net (Loss) Income Per Share:
Basic
Dilutive
Shares used in the computation:
Basic
Dilutive
Income Statement [Abstract]
Net (Loss) Income
Other Comprehensive (Loss) Income
Foreign currency translation adjustments
Comprehensive (Loss) Income
Balance
Balance, shares
Common stock issued on settlement of restricted stock units
Common stock issued on settlement of restricted stock units, shares
Withholding of common stock upon settlement of restricted stock units
Withholding of common stock upon settlement of restricted stock units, shares
Stock-based compensation
Foreign currency translation adjustment
Net income (loss)
Balance
Balance, shares
Statement of Cash Flows [Abstract]
Operating activities:
Net (loss) income
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:
Depreciation and amortization
Gain on sale of fixed assets
Non-cash interest
Stock-based compensation
Provision for reserve on accounts receivable
Provision for excess and obsolete inventory
Other
Changes in operating assets and liabilities:
Accounts receivable
Inventories
Prepaid and other assets
Accounts payable
Accrued liabilities
Net cash (used in) provided by operating activities
Investing activities:
Purchases of property and equipment
Proceeds from sale of fixed assets
Proceeds from divestitures
Net cash provided by (used in) investing activities
Financing activities:
Borrowings on line of credit
Repayments on line of credit
Payments on long-term debt
Debt issuance costs
Payments on financing leases
Payment of taxes from withholding of common stock on settlement of restricted stock units
Net cash used in financing activities
Effect of exchange rate changes on cash and cash equivalents and restricted cash
Net change in cash and cash equivalents and restricted cash
Cash and cash equivalents and restricted cash at beginning of period
Cash and cash equivalents and restricted cash at end of period
Reconciliation of cash and cash equivalents and restricted cash reported in the condensed consolidated balance sheets
Cash and cash equivalents
Restricted cash
Total cash and restricted cash reported in condensed consolidated balance sheets
Pay vs Performance Disclosure [Table]
Executive Category [Axis]
Individual [Axis]
Adjustment to Compensation [Axis]
Measure [Axis]
Pay vs Performance Disclosure, Table
Company Selected Measure Name
Named Executive Officers, Footnote
Peer Group Issuers, Footnote
Changed Peer Group, Footnote
PEO Total Compensation Amount
PEO Actually Paid Compensation Amount
Adjustment To PEO Compensation, Footnote
Non-PEO NEO Average Total Compensation Amount
Non-PEO NEO Average Compensation Actually Paid Amount
Adjustment to Non-PEO NEO Compensation Footnote
Equity Valuation Assumption Difference, Footnote
Compensation Actually Paid vs. Total Shareholder Return
Compensation Actually Paid vs. Net Income
Compensation Actually Paid vs. Company Selected Measure
Total Shareholder Return Vs Peer Group
Compensation Actually Paid vs. Other Measure
Tabular List, Table
Total Shareholder Return Amount
Peer Group Total Shareholder Return Amount
Company Selected Measure Amount
Other Performance Measure, Amount
Adjustment to Compensation, Amount
PEO Name
Name
Non-GAAP Measure Description
Additional 402(v) Disclosure
Pension Benefits Adjustments, Footnote
Equity Awards Adjustments, Footnote
Erroneously Awarded Compensation Recovery [Table]
Restatement Determination Date [Axis]
Restatement Determination Date
Aggregate Erroneous Compensation Amount
Erroneous Compensation Analysis
Stock Price or TSR Estimation Method
Outstanding Aggregate Erroneous Compensation Amount
Aggregate Erroneous Compensation Not Yet Determined
Name
Forgone Recovery due to Expense of Enforcement, Amount
Forgone Recovery due to Violation of Home Country Law, Amount
Forgone Recovery due to Disqualification of Tax Benefits, Amount
Forgone Recovery, Explanation of Impracticability
Name
Compensation Amount
Restatement does not require Recovery
Awards Close in Time to MNPI Disclosures [Table]
Award Timing MNPI Disclosure
Award Timing Method
Award Timing Predetermined
Award Timing MNPI Considered
Award Timing, How MNPI Considered
MNPI Disclosure Timed for Compensation Value
Awards Close in Time to MNPI Disclosures, Table
Name
Underlying Securities
Exercise Price
Fair Value as of Grant Date
Underlying Security Market Price Change
Insider Trading Arrangements [Line Items]
Material Terms of Trading Arrangement
Name
Title
Rule 10b5-1 Arrangement Adopted
Non-Rule 10b5-1 Arrangement Adopted
Adoption Date
Rule 10b5-1 Arrangement Terminated
Non-Rule 10b5-1 Arrangement Terminated
Termination Date
Expiration Date
Arrangement Duration
Aggregate Available
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted
Insider Trading Policies and Procedures Not Adopted
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Business Description, Basis of Presentation and Summary of Significant Accounting Policies
Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]
Sale of Coflex/CoFix Assets and International Hardware Business
Revenue from Contract with Customer [Abstract]
Revenue
Credit Loss [Abstract]
Trade Accounts Receivable, Net
Inventory Disclosure [Abstract]
Inventories
Property, Plant, and Equipment [Abstract]
Property and Equipment, Net
Intangible Asset, Goodwill and Other [Abstract]
Intangible Assets
Payables and Accruals [Abstract]
Accrued Liabilities
Debt Disclosure [Abstract]
Debt
Share-Based Payment Arrangement [Abstract]
Stock-Based Compensation
Warrants
Warrants
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies
Income Tax Disclosure [Abstract]
Income Taxes
Earnings Per Share [Abstract]
Net (Loss) Income Per Share
Supplemental Cash Flow Elements [Abstract]
Supplemental Disclosure of Cash Flow Information
Segment Reporting [Abstract]
Segment and Geographic Information
Subsequent Events [Abstract]
Subsequent Event
Business Description and Basis of Presentation
Use of Estimates
Cash, Cash Equivalents, and Restricted Cash
Long-Lived Assets
Goodwill
Stock-Based Compensation
Recently Issued Accounting Pronouncements
Foreign Currency
Fair Value of Financial Instruments
Summary of Revenues from Product Lines
Schedule of Allowance for Credit Losses
Schedule of Inventories
Schedule of Property and Equipment, Net
Schedule of Intangible of Assets
Schedule of Accrued Liabilities
Schedule of Long-term Debt
Schedule of Principal Payments
Schedule of Stock Options Activity
Schedule of Restricted Stock Activity
Schedule of PSU Awards Activity
Schedule of Warrant Activity
Schedule of Income Taxes
Schedule of Basic and Diluted Earnings Per Share
Schedule of Supplemental Cash Flow Information
Schedule of Calculation of Consolidated Net (Loss) Income
Schedule of Revenues by Geographic Region
Impairments of long-lived assets
Impairments of goodwill
Business Combination [Table]
Business Combination [Line Items]
Future proceeds to be received
Aggregate purchase price in cash
Cash payments
Unsecured promissory note
Payment of unsecured promissory note plus accrued interest
issued and outstanding shares of equity securities
total purchase price
Disaggregation of Revenue [Table]
Disaggregation of Revenue [Line Items]
Total revenue
Percentage of total revenue
Revenue
Beginning balance
Provision for current expected credit losses
(Write-offs) recoveries against allowance
Ending balance
Raw materials
Work in process
Finished goods
Total
Property, Plant, and Equipment [Table]
Property, Plant, and Equipment [Line Items]
Total cost
Less: accumulated depreciation
Property and equipment, net
Depreciation expenses
Intangible Asset, Finite-Lived [Table]
Intangible Asset, Finite-Lived [Line Items]
Weighted avereage life
Intangible assets, gross
Accumulated amortization
Intangible assets, net
Amortization expense
Wages/commissions payable
Taxes payable
Other accrued liabilities
Accrued liabilities
Amounts due under term loan
Accrued end-of-term payments
Less: unamortized debt issuance costs
Less: current portion of long-term debt
Long-term debt, less issuance costs and current portion of long-term debt
Short-Term Debt [Table]
Short-Term Debt [Line Items]
Scheduled quarterly payments
Annually
Line of Credit Facility [Table]
Line of Credit Facility [Line Items]
Effective interest rate
outstanding line of credit
Line of credit facility, remaining borrowing capacity
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Shares, Outstanding, Beginning balance
Weighted Average Exercise Price, Outstanding, Beginning balance
Shares, Cancelled or expired
Weighted Average Exercise Price, Cancelled or expired
Shares, Outstanding, Ending balance
Weighted Average Exercise Price, Outstanding, Ending balance
Weighted Average Remaining Contract Term (Years) Outstanding
Shares, Exercisable, Ending balance
Weighted Average Exercise Price, Exercisable, Ending balance
Weighted Average Remaining Contract Term (years), Exercisable
Shares Outstanding, Beginning balance
Weighted Average Fair Value at Grant Date Per Share, Outstanding, Beginning balance
Shares, Vested
Weighted Average Fair Value at Grant Date Per Share, Vested
Shares, Cancelled
Weighted Average Fair Value at Grant Date Per Share, Cancelled
Shares Outstanding, Ending balance
Weighted Average Fair Value at Grant Date Per Share, Outstanding, Ending balance
Shares, Forfeited
Weighted Average Fair Value, Forfeited
Share based compensation, description
Maximum number of common stock available for issuance
Number of shares available for grant
Share based compensation, award outstanding
Stock-based compensation expense
Unvested employee stock options not yet recognized
Weighted-average period
Compensation cost related to unvested stock units
Number of shares awarded
Vesting rights, percentage
Shares, Outstanding, Beginning balance
Weighted Average Exercise Price, Outstanding, Beginning balance
Shares, Cancelled or expired
Weighted Average Exercise Price, Cancelled or expired
Shares, Outstanding, Ending balance
Weighted Average Exercise Price, Cancelled or expired
Weighted Average Remaining Contractual Term (years), Outstanding
Shares, Exercisable, Ending balance
Weighted Average Exercise Price, Exercisable, Ending balance
Weighted Average Remaining Contractual Term (years), Exercisable
Income tax expense (benefit) from continuing operations
(Loss) income from continuing operations before income taxes
Effective income tax rate
Basic – weighted average shares outstanding
Employee restricted stock units and deferred stock units
Diluted – weighted average shares outstanding
Basic (loss) earnings per share
Diluted (loss) earnings per share
Total number of stock options, RSU, DSU, PSU and warrants excluded for diluted earnings per share
Interest
Less cost of sales
Gross Margin
Interest expense
Interest income
Unrealized foreign currency translation (gain) loss
Other (income) expense
Provision (benefit) for income taxes
Segment Reporting [Table]
Segment Reporting [Line Items]
Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Customer, Extent of Reliance [Table]
Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Customer, Extent of Reliance [Line Items]
Number of reportable segment
Number of operating segment
Concentration risk, percentage
Subsequent Event [Table]
Subsequent Event [Line Items]
Distribution fee paid
Withholding of common stock upon vesting of restricted stock units.
Withholding of common stock upon vesting of restricted stock units share.
Non cash interest.
Provision for expected credit losses.
Adjustments to reconcile net income loss to cash provided by used in operating activities other.
Proceeds from divestiture.
Payment of taxes from with holding of common stock on vesting of restricted stock units.
Coflex/CoFix Agreement [Member]
Companion Spine Llc [Member]
Unsecured promissory note.
Issued and outstanding shares of equity securities percentage.
Paradigm Spine Gmbh [Member]
Bill and Hold Transactions [Member]
Orthobiologics [Member]
Spinal Implant [Member]
License Revenue [Member]
Percentage of total revenue.
Schedule of Principal Payments [Table Text Block]
2027 [Member]
2028 [Member]
2029 [Member]
Remainder of 2026 [Member]
Term Credit Agreement [Member]
Revolving Credit Agreement [Member]
2023 Equity Incentive Plan [Member]
2018 Equity Incentive Plan [Member]
Employees and Directors [Member]
2023 and 2018 Equity Incentive Plan [Member]
Deferred Stock Units and Restricted Stock Units [Member]
Warrants [Text Block]
Schedule of Warrant Activity [Table Text Block]
Share based compensation arrangement by share based payment award non option equity instruments outstanding excercisable number.
Share based compensation arrangement by share based payment award non option equity instruments weighted average grant date fair value.
Share based compensation arrangement by share based payment award non option equity instruments weighted average cancelled or expired grant date fair value.
Share based compensation arrangement by share based payment award non option equity instruments weighted average grant date fair value exercisable.
Sharebased compensation arrangement by sharebased payment non options outstanding and exercisable weighted average remaining contractual term.
Share based compensation arrangement by share based payment non options outstanding and exercisable weighted average remaining contractual term exercisable.
Distribution Agreement [Member]
Computer Software [Member]
Surgical Instruments [Member]
Assets not yet in Service [Member]
Assets, Current
Assets
Liabilities, Current
Liabilities
Equity, Attributable to Parent
Liabilities and Equity
Gross Profit
Operating Expenses [Default Label]
Operating Income (Loss)
Interest Expense, Nonoperating
Nonoperating Income (Expense)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Shares, Outstanding
Gain (Loss) on Disposition of Assets
Increase (Decrease) in Accounts Receivable
Increase (Decrease) in Inventories
Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Accounts Payable
Increase (Decrease) in Accrued Liabilities
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Payments to Acquire Property, Plant, and Equipment
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
Repayments of Lines of Credit
Repayments of Long-Term Debt
Payments of Debt Issuance Costs
Finance Lease, Principal Payments
PaymentOfTaxesFromWithholdingOfCommonStockOnVestingOfRestrictedStockUnits
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation
Restricted Cash and Cash Equivalent
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation
Forgone Recovery, Individual Name
Outstanding Recovery, Individual Name
Awards Close in Time to MNPI Disclosures, Individual Name
Trading Arrangement, Individual Name
Revenue from Contract with Customer [Text Block]
Inventory Disclosure [Text Block]
WarrantsTextBlock
Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]
Share-Based Payment Arrangement [Policy Text Block]
Accounts Receivable, Allowance for Credit Loss, Current
Property, Plant, and Equipment, Accumulated Depreciation, Depletion, and Amortization
Intangible Asset, Finite-Lived, after Accumulated Amortization
Unamortized Debt Issuance Expense
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageGrantDateFairValue
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageCancelledOrExpiredGrantDateFairValue
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingExcercisableNumber
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageGrantDateFairValueExercisable